| # | Drug | Count |
|---|---|---|
| 0 | LISINOPRIL | 26 |
| 1 | ACETAMINOPHEN | 19 |
| 2 | ASPIRIN | 19 |
| 3 | OMALIZUMAB | 19 |
| 4 | RAMIPRIL | 19 |
| 5 | ASPIRIN 325 MG | 17 |
| 6 | ASPIRIN 81 MG | 17 |
| 7 | PREGABALIN | 17 |
| 8 | DEXAMETHASONE | 16 |
| 9 | DEXAMETHASONE 1.5 MG | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CETYLPYRIDINIUM CHLORIDE | 1 | 0.0015 |
| 1 | ECALLANTIDE | 2 | 0.0011 |
| 2 | BREMELANOTIDE | 1 | 0.0009 |
| 3 | PERINDOPRIL ERBUMINE | 3 | 0.0005 |
| 4 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 5 | ARTIFICIAL TEARS | 1 | 0.0004 |
| 6 | STERILE WATER FOR INJECTION | 2 | 0.0004 |
| 7 | ELOSULFASE ALFA | 2 | 0.0004 |
| 8 | PEGVALIASE-PQPZ | 3 | 0.0004 |
| 9 | AMIFAMPRIDINE PHOSPHATE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 53 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 48 |
| 2 | Proton Pump Inhibitor [EPC] | 26 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 20 |
| 4 | Angiotensin Converting Enzyme Inhibitor [EPC] | 19 |
| 5 | Anti-IgE [EPC] | 19 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 16 |
| 7 | Vitamin C [EPC] | 15 |
| 8 | Benzodiazepine [EPC] | 14 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 1 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 2 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 3 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 4 | Phenylalanine Metabolizing Enzyme [EPC] | 3 | 0.0004 |
| 5 | mu-Opioid Receptor Agonist [EPC] | 1 | 0.0003 |
| 6 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 7 | Anti-IgE [EPC] | 19 | 0.0002 |
| 8 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 2 | 0.0001 |